2,661
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study

, , , &
Pages 1977-1986 | Received 21 Dec 2017, Accepted 27 Mar 2018, Published online: 10 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tom M. A. Wilkinson, Peter Van den Steen, Brigitte Cheuvart, Nathalie Baudson, Monique Dodet, Elisa Turriani, Lauriane Harrington, Nadia Meyer, Simona Rondini, Laura Taddei & Piyali Mukherjee. (2021) Seroprevalence of Bordetella pertussis Infection in Patients With Chronic Obstructive Pulmonary Disease in England: Analysis of the AERIS Cohort. COPD: Journal of Chronic Obstructive Pulmonary Disease 18:3, pages 341-348.
Read now

Articles from other publishers (1)

Donald Brandon, Murray Kimmel, Sherine O. Kuriyakose, Lusiné Kostanyan & Narcisa Mesaros. (2018) Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults. Vaccine 36:42, pages 6325-6333.
Crossref